Medical Ikkou Group Co.,Ltd. Stock

Equities

3353

JP3921040006

Drug Retailers

Market Closed - Japan Exchange 01:20:40 2024-06-14 am EDT 5-day change 1st Jan Change
2,600 JPY -1.85% Intraday chart for Medical Ikkou Group Co.,Ltd. 0.00% +26.03%
Sales 2023 33.9B 215M Sales 2024 39.9B 253M Capitalization 8.78B 55.74M
Net income 2023 759M 4.82M Net income 2024 1.04B 6.6M EV / Sales 2023 0.37 x
Net Debt 2023 2.67B 16.97M Net Debt 2024 1.88B 11.92M EV / Sales 2024 0.27 x
P/E ratio 2023
12.8 x
P/E ratio 2024
8.44 x
Employees 1,431
Yield 2023
1.54%
Yield 2024
1.93%
Free-Float 25.95%
More Fundamentals * Assessed data
Dynamic Chart
Medical Ikkou Group Co.,Ltd. agreed to acquire Okinawa Amel Co., Ltd. from Seibu Sawai Yakuhin K.K. CI
Medical Ikkou Group Co.,Ltd. entered into basic agreement to acquire 50% stake in Hakuai Nakai Ethical Pharmacy Co., Ltd. from Kanichi Eguchi. CI
Medical Ikkou Group Co.,Ltd. Reports Earnings Results for the Full Year Ended February 28, 2023 CI
Tranche Update on Medical Ikkou Group Co.,Ltd.'s Equity Buyback Plan announced on June 17, 2020. CI
Medical Ikkou Group Co.,Ltd.'s Equity Buyback announced on June 17, 2020 has expired with 30,900 shares for ¥271.92 million. CI
An unknown buyer acquired an unknown stake in Qol Holdings Co., Ltd. from Medical Ikkou Group Co.,Ltd.. CI
Medical Ikkou Group Co.,Ltd. announces an Equity Buyback for 40,000 shares, representing 2.1% for ¥352 million. CI
Medical Ikkou Group Co.,Ltd. authorizes a Buyback Plan. CI
Medical Ikkou Co., Ltd. cancelled the acquisition of Efa Co., Ltd from Nakagawa Sangyo Co.,Ltd and Takashi Nakagawa. CI
Tranche Update on Medical Ikkou Co., Ltd.'s Equity Buyback Plan announced on November 21, 2018. CI
Medical Ikkou Co., Ltd.'s Equity Buyback announced on November 21, 2018 has expired with 9,900 shares for ¥80.69 million. CI
Medical Ikkou Co., Ltd. announces an Equity Buyback for 15,000 shares, representing 0.78% for ¥122.25 million. CI
Medical Ikkou Co., Ltd. authorizes a Buyback Plan. CI
Medical Ikkou Co., Ltd. agreed to acquire Efa Co., Ltd from Nakagawa Sangyo Co.,Ltd and Takashi Nakagawa. CI
Medical Ikkou Co., Ltd. cancelled the acquisition to acquire Taiho Yakuhin Co., Ltd. from Seiichi Asai. CI
More news
1 day-1.85%
Current month+1.56%
1 month+4.21%
3 months+12.85%
6 months+23.81%
Current year+26.03%
More quotes
1 week
2 600.00
Extreme 2600
2 649.00
1 month
2 457.00
Extreme 2457
2 680.00
Current year
2 063.00
Extreme 2063
2 904.00
1 year
2 025.00
Extreme 2025
2 904.00
3 years
2 025.00
Extreme 2025
3 000.00
5 years
2 025.00
Extreme 2025
4 670.00
10 years
1 425.50
Extreme 1425.5
9 900.00
More quotes
Managers TitleAgeSince
Founder 67 85-04-16
Director of Finance/CFO 70 05-02-28
Chief Administrative Officer - -
Members of the board TitleAgeSince
Founder 67 85-04-16
Corporate Officer/Principal 63 90-12-31
Director of Finance/CFO 70 05-02-28
More insiders
Date Price Change Volume
24-06-14 2,600 -1.85% 100
24-06-11 2,649 +1.88% 200
24-06-07 2,600 -1.89% 300

Delayed Quote Japan Exchange, June 14, 2024 at 01:20 am EDT

More quotes
Medical Ikkou Group Co.,Ltd. is a Japan-based company mainly engaged in the operation of dispensing pharmacies that fill prescriptions for general patients based on the medical prescriptions issued by medical institutions. The Company operates in four business segments. The Dispensing Pharmacy segment is specialized in the sale of medical drugs based on medical prescriptions. The Healthcare segment is engaged in the operation of nursing care facilities, the leasing of medical facilities and others, as well as the medical care and nursing care related businesses. The Medicine Wholesale segment is engaged in the sale of pharmaceutical products to medical institutions and others. The Real Estate segment is engaged in the leasing of real estate properties.
Calendar
More about the company